← feed

Is NCT02146313 results overdue?

Yes — results are overdue. Primary completion was 2018-06-18; the FDAAA-801 reporting deadline (2019-06-18) passed 2606 days ago and no results are posted on ClinicalTrials.gov.

A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer

NCT IDNCT02146313 ↗
SponsorGenentech, Inc. (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2018-06-18 (ACTUAL)
Reporting deadline2019-06-18 (completion + 365d)
Days overdue2606
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 bc7460dad1a9b99f… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT02146313. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →